Packed poster session. #EULAR2019 @RheumNow pic.twitter.com/hYpYhAYkn5
— Janet Pope (@Janetbirdope) June 14, 2019
Small RCT showed aerobic exercise training but not supervised exercise without training helped axial SpA. However could be under powered but reminds us to use supervised aerobic exercise for SpA FRI0703 #EULAR2019 @RheumNow
— Janet Pope (@Janetbirdope) June 14, 2019
Dr Alex So reviews his selection of #gout #uratedepositiondisease highlights Days 1-3 at EULAR 2019 in Madrid #EULAR2019 @RheumNow https://t.co/IqIfXBkv24
— Gout Study Group (@GoutGroup) June 14, 2019
Do you routinely recommend specific exercises for your pts with axial SpA? FRI0703 #EULAR2019 @RheumNow
— Janet Pope (@Janetbirdope) June 14, 2019
Machine learning in PsA separates phenotypes. (2/2) OP0114. Dr Iain McInnes #EULAR2019 @RheumNow pic.twitter.com/wgCnnTNpYc
— Janet Pope (@Janetbirdope) June 14, 2019
Machine learning in PsA separates phenotypes. (1/2) OP0114. Dr Iain McInnes #EULAR2019 @RheumNow pic.twitter.com/0nUI3eIoZ0
— Janet Pope (@Janetbirdope) June 14, 2019
ANCA can occur with infection such as TB and SBE. If both p and cANCA are + think of cocaine esp with methamizole added. pANCA is more nonspecific and even can occur in IBD. Use clinical judgement. Study of ANCA PR3 (7%) & 0% MPO in TB FRI0649 #EULAR2019 @RheumNow
— Janet Pope (@Janetbirdope) June 14, 2019
Checklists for RA patient ‘screening’: bad. How useful is a routine ANA, even for early RA assessment? This is what happens when you do it on every patient in an early RA clinic… whole lotta false positives. #EULAR2019 OP0323 Mariana Luis from Coimbra, Portugal @RheumNow pic.twitter.com/wa8PzVbais
— David Liew (@drdavidliew) June 14, 2019
This is a nice study but does not address effects on CRITICAL and PATHOGENIC autoantibody production- Prosepctive studies are urgently needed in SLE and AAV among others @GSKUS @Lupusdoc @LupusOrg @LupusResearch @RheumNow @HealioRheum @CCalabreseDO #shingles https://t.co/7yhHmQfphY
— Leonard Calabrese (@LCalabreseDO) June 14, 2019
Sorry to have missed this critical session – but feeling better- Closing the gap between pateint and provider is the new horizon in well being as opposed to health All reports of #EULAR2019 are terrific and following on @RheumNow #empathy https://t.co/DUhlRMtrDX
— Leonard Calabrese (@LCalabreseDO) June 14, 2019
Analysis from the BSRBR ankylosing spondylitis registry of 2420 AS pts shows that HLA-B27 is associated with an increased risk of anterior uveitis but a decreased risk of psoriasis and IBD. #Eular2019 OP0262 pic.twitter.com/jslLYkMr9Q
— Dr. John Cush (@RheumNow) June 14, 2019
Do you stop #methotrexate in your male patients who wish to conceive? No need to do so according to studies from the past few years: no increase in adverse pregnancy outcomes if paternal exposure. Prof. Monika Ostensen at #EULAR2019 >LA
— ARD & RMD Open (@ARD_BMJ) June 14, 2019
Gr8. Tocilizumab in GCA – data we’ve been waiting to see RT @chechitap: #EULAR2019 giacta long term pic.twitter.com/UEFX4fY3Nw
— Dr Irwin Lim (@_connectedcare) June 13, 2019
Shingrix can be give to inflammatory arthritis pts? Collective report from the Brigham & Women’s Hospital looked at the safety of Shingrix given to 300 RA, PsA, etc patient without any reports of H.Zoster and a 4% rate of "flares". #EULAR2019 FRI0068 https://t.co/Wkx5V9vM8r pic.twitter.com/kErMMU97tB
— Dr. John Cush (@RheumNow) June 14, 2019
What’s next in biosimilars? Visit RheumNow to listen to experts discuss this and more in "Therapeutic Update: Biosimilars in Rheumatology," a video series sponsored by Sandoz, Inc. https://t.co/1vmnEJqOSi #sponsored #biosimilars
— Dr. John Cush (@RheumNow) June 14, 2019
Dr. Gerd Burmester reviews the SEMIRA study that examines whether or not you should wean that 5mg Prednisone in your RA patients. #EULAR2019 https://t.co/Vk0salb8bX
— Dr. John Cush (@RheumNow) June 14, 2019
Very interesting. Another strike against steroids…? https://t.co/LGz7fKh9hU
— Dr. Paul Sufka (@psufka) June 14, 2019
Updated treatment algorithm for extrarenal #Lupus
👉🏻 MSK
👉🏻 Skin
👉🏻 Hematological
👉🏻 Cardiovascular
👉🏻 Lung
👉🏻Serositis
👉🏻 Vasculitis #EULAR2019 pic.twitter.com/LDr0hKZAfV— Juan Ovalles, MD, PhD (@DrJuanOvalles) June 13, 2019
JAK system really important for many bodily functions. So the aim is to “turn down the thermostat” without “turning it off” Ernest Choy #EULAR2019 pic.twitter.com/863ktP3CIg
— Dr Irwin Lim (@_connectedcare) June 14, 2019
#EULAR2019 session ‘Getting A Grip on The Comorbidities in Gout’ focused on the complex and variable disease profile patients experience and clinicians treat. Do #gout co-morbidities occur in patterns? Dr Ed Roddy discusses. Abstract SP0061 @RheumNow pic.twitter.com/EHoNdP7iMo
— Gout Study Group (@GoutGroup) June 14, 2019
Baracitinib affects JAK2 more than Tofacitinib. Difference can be seen with lower Hb & higher platelets #EULAR2019 pic.twitter.com/BfzuyZI8f9
— Dr Irwin Lim (@_connectedcare) June 14, 2019
This graph is a reminder that over time, the level of Inflammation in RA may reduce with lower symptoms. However, CUMULATIVE inflam leads to increasing damage & disability #EULAR2019 pic.twitter.com/ujhODMOp4E
— Dr Irwin Lim (@_connectedcare) June 14, 2019